bVibrio parahaemolyticus is commonly resistant to ampicillin, yet the mechanisms underlying this phenomenon are not clear. In this study, a novel class A carbenicillin-hydrolyzing -lactamase (CARB) family of -lactamases, bla CARB-17 , was identified and found to be responsible for the intrinsic penicillin resistance in V. parahaemolyticus. Importantly, bla CARB-17 -like genes were present in all 293 V. parahaemolyticus genome sequences available in GenBank and detectable in all 91 V. parahaemolyticus food isolates, further confirming the intrinsic nature of this gene.
Vibrio parahaemolyticus is a major causative agent of gastroenteritis in areas with high seafood consumption rates and has recently become pandemic due to the emergence of the serotype O3:K6 (1). In Hong Kong, V. parahaemolyticus is the leading cause of food-borne illnesses due to the high rate of seafood consumption among the population (2). Although most cases of infections are self-limiting, fatality can occur among immunocompromised patients or those with debilitating medical conditions such as liver disease or diabetes (3). Antibiotics such as ciprofloxacin can be used for the treatment of infections caused by V. parahaemolyticus strains, but the choice of antibiotics should be based on the antimicrobial susceptibilities of the organism. V. parahaemolyticus is commonly considered highly susceptible to virtually all antimicrobials except for penicillins. However, mechanisms mediating the development of penicillin resistance in V. parahaemolyticus are not clear. In this study, we identified a novel carbenicillin-hydrolyzing -lactamase (CARB) from chromosome 2 of V. parahaemolyticus and showed that the product of this gene is responsible for the intrinsic resistance to penicillins in V. parahaemolyticus.A novel potential -lactamase gene, bla V110 , with a length of 852 bp was identified through bioinformatics analysis of the whole-genome sequence of V. parahaemolyticus V110, which was shown to be resistant to ampicillin (4). The full-length novel -lactamase gene was amplified by PCR using primer set F-GCT GAGAGCTCATGAAAAAGTTA, R-CGTAGGATCCTTAACTT TCTTTGTAGTGC and then cloned into Escherichia coli BL21 and tested for the MICs of various -lactams according to CLSI standards (5). E. coli BL21 isolates expressing the novel -lactamase gene exhibited MICs of 256, 512, 256, and 1,024 g/ml toward penicillin G, ampicillin, carbenicillin, and piperacillin, respectively. The Bla V110 enzyme appears to be susceptible to -lactamase inhibitors such as clavulanic acid, sulbactam, and tazobactam (Table 1). To verify whether the penicillin resistance phenotype was attributed to the expression of bla V110 , we further purified a truncated form (60 to 852 bp) of this -lactamase in which the signal peptide was removed and designated mBla V110 . The mBla V110 protein was purified through several steps, including a Ni-nitrilotriacetic acid (NTA) column, thrombin treatment to remove the His tag, and a size exclusion column as previously described (6) (see Fig....